"Heart Valve Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Descriptor ID |
D006349
|
| MeSH Number(s) |
C14.280.484
|
| Concept/Terms |
Heart Valve Diseases- Heart Valve Diseases
- Disease, Heart Valve
- Diseases, Heart Valve
- Heart Valve Disease
- Valve Disease, Heart
- Valve Diseases, Heart
- Valvular Heart Diseases
- Disease, Valvular Heart
- Diseases, Valvular Heart
- Heart Disease, Valvular
- Heart Diseases, Valvular
- Valvular Heart Disease
|
Below are MeSH descriptors whose meaning is more general than "Heart Valve Diseases".
Below are MeSH descriptors whose meaning is more specific than "Heart Valve Diseases".
This graph shows the total number of publications written about "Heart Valve Diseases" by people in this website by year, and whether "Heart Valve Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 3 | 4 |
| 2004 | 1 | 2 | 3 |
| 2005 | 1 | 3 | 4 |
| 2006 | 2 | 1 | 3 |
| 2007 | 3 | 2 | 5 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 1 | 3 |
| 2011 | 5 | 0 | 5 |
| 2012 | 4 | 0 | 4 |
| 2013 | 6 | 0 | 6 |
| 2014 | 3 | 0 | 3 |
| 2015 | 4 | 0 | 4 |
| 2016 | 2 | 1 | 3 |
| 2017 | 4 | 1 | 5 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 5 | 0 | 5 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heart Valve Diseases" by people in Profiles.
-
The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes: Developed by a multisociety taskforce coordinated by the Heart Valve Society (HVS) including the American Heart Association (AHA), the American College of Cardiology (ACC), the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology (ESC), The Society of Thoracic Surgeons (STS), the Australian & New Zealand Society of Cardiac & Thoracic Surgeons (ANZSCTS), the International Society for Applied Cardiovascular Biology (ISACB), the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), the South African Heart Association (SHA), Heart Valve Voice, and Global Heart Hub. Circ Cardiovasc Qual Outcomes. 2025 Mar; 18(3):e000128.
-
The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes. Eur J Cardiothorac Surg. 2025 Feb 04; 67(2).
-
Assessment of valve regurgitation severity via contrastive learning and multi-view video integration. Phys Med Biol. 2024 Feb 12; 69(4).
-
Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival. Curr Probl Cardiol. 2024 Apr; 49(4):102417.
-
Diagnosis and Management of Aortic Diseases. JAMA. 2024 01 23; 331(4):352-353.
-
Late Pulmonary Autograft Dilation: Can We Make a Good Operation Great? The Tailored Approach. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2024; 27:42-46.
-
Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report From the American Society of Echocardiography Developed in Collaboration With the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2024 01; 37(1):2-63.
-
Hemodynamic Consequences of Long-Term Continuous Flow: The Importance of the Right Ventricular-Aortic Valve Interactions. Circ Heart Fail. 2023 10; 16(10):e010713.
-
PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves. Circ Res. 2023 09; 133(6):463-480.
-
Management of Incidental Aortic Valve Mass. J Cardiothorac Vasc Anesth. 2023 08; 37(8):1495-1502.